Baxan en es it fr

Baxan Brand names, Baxan Analogs

Baxan Brand Names Mixture

  • None

Baxan Chemical_Formula


Baxan RX_link

Baxan fda sheet

Baxan msds (material safety sheet)

Baxan Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Baxan Molecular Weight

363.389 g/mol

Baxan Melting Point


Baxan H2O Solubility

1110 mg/L

Baxan State


Baxan LogP


Baxan Dosage Forms

Capsule; Tablet; Oral liquid

Baxan Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Baxan Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Baxan Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Baxan side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Baxan Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Baxan Organisms Affected

Enteric bacteria and other eubacteria